|
Volumn 121, Issue , 2016, Pages 158-168
|
Synthetic strategy and antiviral evaluation of diamide containing heterocycles targeting dengue and yellow fever virus
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIVIRUS AGENT;
DIAMIDE;
IMIDAZOLE;
N1 (4 FLUOROPHENYL) N2 [2 (THIOPHEN 3 YL)BENZYL]PHTHALAMIDE;
N1 (4 FLUOROPHENYL) N2 [4 (THIOPHEN 3 YL)BENZYL]PHTHALAMIDE;
N1 (4 FLUOROPHENYL) N2 [4 METHYL 2 (3 METHYL 1H PYRAZOL 5 YL)PHENYL]PHTHALAMIDE;
N1 (4 FLUOROPHENYL) N2 [4 METHYL 2 (5 METHYLTHIOPHEN 2 YL)PHENYL]PHTHALAMIDE;
N1 (4 FLUOROPHENYL) N2 [4 METHYL 2 (THIOPHEN 2 YL)PHENYL]PHTHALAMIDE;
N1 (4 FLUOROPHENYL) N2 [4 METHYL 2 (THIOPHEN 3 YL)PHENYL]PHTHALAMIDE;
N1 [4 (THIOPHEN 3 YL)BENZYL] N2 (4 TOLYL)PHTHALAMIDE;
N1 [4 METHYL 2 (3 METHYL 1H PYRAZOL 5 YL)PHENYL] N2 (4 TOLYL)PHTHALAMIDE;
N1 [4 METHYL 2 (5 METHYLTHIOPHEN 2 YL)PHENYL] N2 (4 TOLYL)PHTHALAMIDE;
N1 [4 METHYL 2 (THIOPHEN 2 YL)PHENYL] N2 (4 TOLYL)PHTHALAMIDE;
N1 [4 METHYL 2 (THIOPHEN 3 YL)PHENYL] N2 (4 TOLYL)PHTHALAMIDE;
N2 (4 FLUOROPHENYL) N3 [2 (3 METHYL 1H PYRAZOL 5 YL)PHENYL]PYRAZINE 2,3 DICARBOXAMIDE;
N2 (4 FLUOROPHENYL) N3 [2 (THIOPHEN 3 YL)BENZYL]PYRAZINE 2,3 DICARBOXAMIDE;
N2 (4 FLUOROPHENYL) N3 [4 (THIOPHEN 3 YL)BENZYL]PYRAZINE 2,3 DICARBOXAMIDE;
N2 (4 FLUOROPHENYL) N3 [4 METHYL 1H PYRAZOL 5 YL)PHENYL]PYRAZINE 2,3 DICARBOXAMIDE;
N2 (4 FLUOROPHENYL) N3 [4 METHYL 2 ( THIOPHEN 3 YL)PHENYL]PYRAZINE 2,3 DICARBOXAMIDE;
N2 (4 FLUOROPHENYL) N3 [4 METHYL 2 (5 METHYLTHIOPEN 2 YL)PHENYL]PYRAZINE 2,3 DICARBOXAMIDE;
N2 (4 FLUOROPHENYL) N3 [4 METHYL 2 (THIOPHEN 2 YL)PHENYL]PYRAZINE 2,3 DICARBOXAMIDE;
N2 [2 (3 METHYL 1H PYRAZOL 5 YL)PHENYL] N3 (4 TOLYL)PYRAZINE 2,3 DICARBOXAMIDE;
N2 [2 (THIOPHEN 3 YL)BENZYL] N3 (4 TOLYL)PYRAZINE 2,3 DICARBOXAMIDE;
N2 [4 (THIOPHEN 3 YL)BENZYL] N3 (4 TOLYL)PYRAZINE 2,3 DICARBOXAMIDE;
N2 [4 METHYL 2 (3 METHYL 1H PYRAZOL 5 YL)PHENYL] N3 (4 TOLYL)PYRAZINE 2,3 DICARBOXAMIDE;
N2 [4 METHYL 2 (5 METHYLTHIOPEN 2 YL)PHENYL] N3 (4 TOLYL)PYRAZINE 2,3 DICARBOXAMIDE;
N2 [4 METHYL 2 (THIOPEN 2 YL)PHENYL] N3 (4 TOLYL)PYRAZINE 2,3 DICARBOXAMIDE;
N2 [4 METHYL 2 (THIOPHEN 3 YL)PHENYL] N3 (4 TOLYL)PYRAZINE 2,3 DICARBOXAMIDE;
PYRAZINE DERIVATIVE;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
HETEROCYCLIC COMPOUND;
ANTIVIRAL ACTIVITY;
ARTICLE;
DENGUE VIRUS;
DRUG DESIGN;
DRUG POTENCY;
DRUG SELECTIVITY;
DRUG TARGETING;
HIGH THROUGHPUT SCREENING;
NONHUMAN;
VIRUS REPLICATION;
YELLOW FEVER VIRUS;
ANIMAL;
CHEMISTRY;
CHLOROCEBUS AETHIOPS;
DRUG DEVELOPMENT;
DRUG EFFECTS;
PROCEDURES;
STRUCTURE ACTIVITY RELATION;
VERO CELL LINE;
ANIMALS;
ANTIVIRAL AGENTS;
CERCOPITHECUS AETHIOPS;
DENGUE VIRUS;
DIAMIDE;
DRUG DISCOVERY;
HETEROCYCLIC COMPOUNDS;
STRUCTURE-ACTIVITY RELATIONSHIP;
VERO CELLS;
VIRUS REPLICATION;
YELLOW FEVER VIRUS;
|
EID: 84971324424
PISSN: 02235234
EISSN: 17683254
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (37)
|
References (15)
|